About CCR Ostrava, s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Incyte Corporation
2
Bristol-Myers Squibb
1
Celgene
1
Fresenius Kabi SwissBioSim GmbH
1
Gilead Sciences
1
H. Lundbeck A/S
1
Kowa Research Institute, Inc.
1
NewAmsterdam Pharma
1
Clinical Trials at CCR Ostrava, s.r.o.
During the past decade, CCR Ostrava, s.r.o. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
2018-12-20
2020-11-09
Completed
618
Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
2019-04-01
2021-01-27
Completed
203
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
2019-12-03
2021-05-11
Terminated
67
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
2020-07-29
2022-02-07
Completed
460
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
2020-06-01
2022-09-15
Completed
892
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCR Ostrava, s.r.o." #1 sponsor was "Pfizer" with 3 trials, followed by "Incyte Corporation" with 2 trials
sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Fresenius Kabi SwissBioSim GmbH"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCR Ostrava, s.r.o."
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at CCR Ostrava, s.r.o.
According to Clinical.Site data, the most researched conditions in "CCR Ostrava, s.r.o." are
"Dermatitis, Atopic" (2 trials), "Active Psoriatic Arthritis" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atopic Dermatitis" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "CCR Ostrava, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at CCR Ostrava, s.r.o.
Most popular intervention types in "CCR Ostrava, s.r.o." are "Drug" (12 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ruxolitinib cream" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CCR Ostrava, s.r.o.
The vast majority of trials in "CCR Ostrava, s.r.o." are
11 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CCR Ostrava, s.r.o.
Currently, there are NaN active trials in "CCR Ostrava, s.r.o.".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in CCR Ostrava, s.r.o.,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in CCR Ostrava, s.r.o., 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".